Urofollitropin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Urofollitropin

Clinical data
ATC code	G03GA04 (WHO)
Identifiers
IUPAC name Human follicle stimulating hormone
CAS Number	146479-72-3
DrugBank	BTD00104
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C975H1513N267O304S26
Molar mass	22672.9 g/mol

WikiDoc Resources for Urofollitropin
Articles
Most recent articles on Urofollitropin Most cited articles on Urofollitropin Review articles on Urofollitropin Articles on Urofollitropin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Urofollitropin Images of Urofollitropin Photos of Urofollitropin Podcasts & MP3s on Urofollitropin Videos on Urofollitropin
Evidence Based Medicine
Cochrane Collaboration on Urofollitropin Bandolier on Urofollitropin TRIP on Urofollitropin
Clinical Trials
Ongoing Trials on Urofollitropin at Clinical Trials.gov Trial results on Urofollitropin Clinical Trials on Urofollitropin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Urofollitropin NICE Guidance on Urofollitropin NHS PRODIGY Guidance FDA on Urofollitropin CDC on Urofollitropin
Books
Books on Urofollitropin
News
Urofollitropin in the news Be alerted to news on Urofollitropin News trends on Urofollitropin
Commentary
Blogs on Urofollitropin
Definitions
Definitions of Urofollitropin
Patient Resources / Community
Patient resources on Urofollitropin Discussion groups on Urofollitropin Patient Handouts on Urofollitropin Directions to Hospitals Treating Urofollitropin Risk calculators and risk factors for Urofollitropin
Healthcare Provider Resources
Symptoms of Urofollitropin Causes & Risk Factors for Urofollitropin Diagnostic studies for Urofollitropin Treatment of Urofollitropin
Continuing Medical Education (CME)
CME Programs on Urofollitropin
International
Urofollitropin en Espanol Urofollitropin en Francais
Business
Urofollitropin in the Marketplace Patents on Urofollitropin
Experimental / Informatics
List of terms related to Urofollitropin

Urofollitropin (brand names Bravelle®, Fertinex®, Follistim®, and Gonal-F®)is a purified form of follicle-stimulating hormone (FSH). FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. It is also used with in vitro fertilization methods. The dosage is adjusted to each individual's response.

Its side effects include breast tenderness, mild diarrhea, nausea, or vomiting.